3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Conditions
Frailty
10
Neoplasms
7
Lymphoma
4
Breast Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
2
Colorectal Neoplasms
2
Urogenital Neoplasms
1
Treatment Adherence and Compliance
1
Stomach Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Sarcoma
1
Prostate Cancer Cured
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hepatic Malignancies
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematologic Neoplasms
1
Health Education
1
Head and Neck Neoplasms
1
Communication
1
Cognitive Dysfunction
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
8
Peripheral Blood Stem Cell Transplantation
7
Busulfan
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Methylprednisolone
4
Methotrexate
4
Filgrastim
4
Cyclosporine
4
Psychiatric Rehabilitation
3
Whole-Body Irradiation
2
Therapeutics
2
Tacrolimus
2
Radiotherapy
2
Mycophenolic Acid
2
Melphalan
2
Etoposide
2
Blood Specimen Collection
2
Aprepitant
2
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Ultraviolet Therapy
1
Thiotepa
1
Thalidomide
1
Tai Ji
1
Surveys and Questionnaires
1
Restraint, Physical
1
Resistance Training
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms, Plasma Cell
×
Geriatric Assessment
×
Clear all
NCT05101759
2024-09-25
LYMPHOLD
University Hospital, Toulouse
Phase NA
Completed
100 enrolled